Robotic Procedure Helps Treat Macular Degeneration
By Dennis Thompson HealthDay Reporter
THURSDAY, June 12, 2024 -- Robot-guided radiation therapy can improve treatment for age-related macular degeneration, the leading cause of vision loss and blindness among American seniors, a new study shows.
Precisely targeted radiation treatment reduced by a quarter the number of routine injections needed to treat wet-type age-related macular degeneration (AMD), the most advanced and serious form of the disorder, researchers reported June 11 in The Lancet journal.
“With this purpose-built robotic system, we can be incredibly precise, using overlapping beams of radiation to treat a very small lesion in the back of the eye,” said lead researcher Timothy Jackson, a consultant ophthalmic surgeon at King’s College Hospital in London.
Wet AMD occurs when new, abnormal blood vessels grow under the retina. These vessels leak blood and other fluid, causing scarring of the macula -- the center of the retina -- and rapid vision loss.
Standard treatment for wet AMD involves injections of drugs that inhibit the growth of new blood vessels in the eye. Most patients require an injection every one to three months to keep fluid from building up, researchers said.
“Patients generally accept that they need to have eye injections to help preserve their vision, but frequent hospital attendance and repeated eye injections isn’t something they enjoy,” Jackson said in a King's College news release.
In the new therapy, the eye is treated once using three beams of highly focused radiation that are aimed by a robot directly at the site of abnormal blood vessel growth.
More than 400 British patients with AMD who received the robotic radiation therapy wound up needing about a quarter fewer injections.
Globally, about 196 million people have AMD. Given their results, researchers said robotic radiation treatment could potentially save around 1.8 million injections per year worldwide.
The treatment also could save money within the health care system, researchers added.
“We found that the savings from giving fewer injections are larger than the cost of robot-controlled radiotherapy,” said researcher Helen Dakin, a research lecturer at the University of Oxford.
Sources
- King’s College London, news release, June 11, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2024
Read this next
How to Predict Who Will Respond to Glaucoma Treatment -- and Who Won't
TUESDAY, July 16, 2024 -- An experimental blood test might be able to predict whether glaucoma patients will continue to lose their vision following treatment, researchers...
GLP-1 Drugs Ozempic, Wegovy Linked to Rare Blinding Condition
WEDNESDAY, July 3, 2024 -- Trendy weight-loss drugs appear to increase the risk of a rare and potentially blinding eye condition, a new study warns. People with diabetes...
Protect Your Eyes From Summer's Dangers
SATURDAY, June 15, 2024 -- Summertime is primetime for the great outdoors, but that can mean new hazards for your eyes, one expert warned. Simple steps can help cut the risk...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
